Alpha Tau Medical (DRTS) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.13
- EPS estimate
- −$0.11
- EPS surprise
- −17.33%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 11, 2025
Alpha Tau Medical's most recent results in the table are for Q2 2025, reported on August 11, 2025. It posted a loss of $0.13 per share, against an expected loss of $0.11, a miss of 17.33%. A year earlier, in Q2 2024, the loss was $0.11 per share. No revenue is shown for any quarter in the table, and no revenue estimate was given for Q2 2025.
Every one of the 15 quarters in the table, from Q4 2021 to Q2 2025, was a loss. Full-year losses were $0.66 per share in 2022, $0.67 in 2023 and $0.45 in 2024, and the first half of 2025 adds up to a loss of $0.25. The largest loss was $0.54 in Q1 2022, and the smallest were $0.03 to $0.05 in the last three quarters of 2022. Alpha Tau beat the EPS estimate in 8 of the 15 quarters. The table gives no report date for Q2 2024.
The table holds no results after Q2 2025, so later quarters are not shown. In earlier years, Q3 results came in mid-to-late November and Q4 results in March. The next update will show whether the losses continue.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 11, 2025 | −$0.11 | −$0.13 | −17.33% | $0.00 | SEC |
| Q1 2025 | May 19, 2025 | −$0.12 | −$0.12 | +2.04% | $0.00 | SEC |
| Q4 2024 | Mar 12, 2025 | −$0.13 | −$0.13 | −2.00% | $0.00 | SEC |
| Q3 2024 | Nov 19, 2024 | −$0.12 | −$0.10 | +16.87% | $0.00 | SEC |
| Q2 2024 | Invalid Date | −$0.12 | −$0.11 | +4.35% | $0.00 | — |
| Q1 2024 | May 20, 2024 | −$0.13 | −$0.11 | +13.66% | $0.00 | SEC |
| Q4 2023 | Mar 7, 2024 | −$0.12 | −$0.11 | +6.70% | $0.00 | SEC |
| Q3 2023 | Nov 16, 2023 | −$0.12 | −$0.31 | −158.33% | $0.00 | SEC |
| Q2 2023 | Aug 28, 2023 | −$0.13 | −$0.13 | −1.96% | $0.00 | SEC |
| Q1 2023 | May 23, 2023 | −$0.11 | −$0.12 | −8.89% | $0.00 | SEC |
| Q4 2022 | Mar 9, 2023 | −$0.09 | −$0.05 | +46.64% | $0.00 | SEC |
| Q3 2022 | Nov 22, 2022 | −$0.12 | −$0.04 | +65.43% | $0.00 | — |
| Q2 2022 | Aug 25, 2022 | −$0.12 | −$0.03 | +74.77% | $0.00 | — |
| Q1 2022 | May 26, 2022 | −$0.07 | −$0.54 | −634.69% | $0.00 | — |
| Q4 2021 | Mar 28, 2022 | −$0.07 | −$0.29 | −314.29% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Alpha Tau Medical (DRTS) last report earnings?
Alpha Tau Medical last reported on Aug 11, 2025, covering fiscal Q2 2025.
Did DRTS beat earnings estimates?
No. Alpha Tau Medical reported EPS of −$0.13 for Q2 2025 against a −$0.11 estimate — a 17.33% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.